Retraction notice to "Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer" [Biomed. Pharmacother. 106 (2018) 61-67]
- PMID: 40818929
- DOI: 10.1016/j.biopha.2025.118383
Retraction notice to "Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer" [Biomed. Pharmacother. 106 (2018) 61-67]
Retraction of
-
Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.Biomed Pharmacother. 2018 Oct;106:61-67. doi: 10.1016/j.biopha.2018.06.112. Epub 2018 Jun 26. Biomed Pharmacother. 2018. Retraction in: Biomed Pharmacother. 2025 Aug 15:118383. doi: 10.1016/j.biopha.2025.118383. PMID: 29957467 Retracted.
Similar articles
-
Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.Biomed Pharmacother. 2018 Oct;106:61-67. doi: 10.1016/j.biopha.2018.06.112. Epub 2018 Jun 26. Biomed Pharmacother. 2018. Retraction in: Biomed Pharmacother. 2025 Aug 15:118383. doi: 10.1016/j.biopha.2025.118383. PMID: 29957467 Retracted.
-
Expression of Concern.Eur Rev Med Pharmacol Sci. 2025 Jun;29(6):287-288. doi: 10.26355/eurrev_202506_37270. Eur Rev Med Pharmacol Sci. 2025. PMID: 40613620
-
Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].Biomed Pharmacother. 2022 Sep;153:113356. doi: 10.1016/j.biopha.2022.113356. Epub 2022 Jul 11. Biomed Pharmacother. 2022. PMID: 35835667 No abstract available.
-
Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].Biomed Pharmacother. 2023 Dec 31;169:115376. doi: 10.1016/j.biopha.2023.115376. Epub 2023 Nov 27. Biomed Pharmacother. 2023. PMID: 38016887 No abstract available.
-
Retraction notice to "Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p" [Biomed. Pharmacother. 108 (2018) 1022-1028].Biomed Pharmacother. 2022 Sep;153:113354. doi: 10.1016/j.biopha.2022.113354. Epub 2022 Jul 11. Biomed Pharmacother. 2022. PMID: 35835664 No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources